Taxol Carboplatin and Erythropoetin
NCT00158379 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 105
Last updated 2017-02-06
Summary
Time to progression (physical examination and radiologic imaging
Conditions
Interventions
- DRUG
-
4 cycles of Carboplatin AUC 5 every 3 weeks. 12 weekly infusions of 80 mg/m² Taxol®
Sponsors & Collaborators
-
North Eastern German Society of Gynaecological Oncology
lead OTHER
Principal Investigators
-
Jalid Sehouli · Charite University, Berlin, Germany
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-06-30
More Related Trials
-
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
NCT00004037 ·Status: TERMINATED ·Phase: PHASE2
-
Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer
NCT00189579 ·Status: TERMINATED ·Phase: PHASE2
-
Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer
NCT00170677 ·Status: COMPLETED ·Phase: PHASE2
-
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum
NCT00189371 ·Status: TERMINATED ·Phase: PHASE3
-
Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse
NCT00189566 ·Status: COMPLETED ·Phase: PHASE2
-
Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma
NCT00193297 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer
NCT00003732 ·Status: COMPLETED ·Phase: PHASE2
-
Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
NCT00217529 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer
NCT03936270 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003560 ·Status: UNKNOWN ·Phase: PHASE2
-
Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
NCT00758732 ·Status: TERMINATED ·Phase: PHASE2
-
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT00075543 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT00006454 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00003385 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer
NCT00772798 ·Status: UNKNOWN ·Phase: PHASE2
-
Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer
NCT00170625 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
NCT00052468 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma
NCT02107378 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT00657878 ·Status: UNKNOWN ·Phase: PHASE3
-
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
NCT01506856 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer
NCT02399592 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT01570582 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer
NCT03690739 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
NCT01460979 ·Status: COMPLETED ·Phase: PHASE2
-
Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma
NCT00059787 ·Status: COMPLETED ·Phase: PHASE2